{"name":"Ondansetron","slug":"ondansetron","kind":"substance","abbreviations":[],"systematic":null,"aliases":["Zudan","Zofran ODT","Zuplenz","ondansetronum","ondasetron","Ondansetron ODT","A04aa01","Eur-1025","Monohydrochloride, Ondansetron","Odansetron (common misspelling of ondansetron)"],"brands":[],"scraped":true,"has_structure":true,"cid":4595,"classes":[],"families":[{"name":"phenethylamine","href":"/substituted/phenethylamine"}],"physical":[{"label":"Molecular mass","value":"293.40 g/mol","copyable":false},{"label":"Appearance","value":"Crystals from methanol","copyable":false},{"label":"Melting point","value":"231-232 °C","copyable":false},{"label":"Solubility","value":"Sparingly soluble in water","copyable":false},{"label":"Predicted LogP","value":"2.3","copyable":false}],"identifiers":[{"label":"Molecular formula","value":"C<sub>18</sub>H<sub>19</sub>N<sub>3</sub>O","copyable":true},{"label":"IUPAC name","value":"9-methyl-3-[(2-methylimidazol-1-yl)methyl]-2,3-dihydro-1H-carbazol-4-one","copyable":true},{"label":"SMILES","value":"CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C","copyable":true},{"label":"InChI","value":"InChI=1S/C18H19N3O/c1-12-19-9-10-21(12)11-13-7-8-16-17(18(13)22)14-5-3-4-6-15(14)20(16)2/h3-6,9-10,13H,7-8,11H2,1-2H3","copyable":true},{"label":"InChIKey","value":"FELGMEQIXOGIFQ-UHFFFAOYSA-N","copyable":true},{"label":"CAS number","value":"99614-02-5","copyable":true},{"label":"UNII","value":"4AF302ESOS","copyable":true},{"label":"PubChem CID","value":"4595","copyable":true}],"pharmacokinetics":[{"label":"Elimination half-life","value":"5.7 hours","copyable":false},{"label":"Metabolism","value":"Liver (CYP3A4, CYP1A2, CYP2D6)","copyable":false},{"label":"Excretion","value":"Kidney","copyable":false},{"label":"Routes of administration","value":"By mouth, rectal, intravenous, intramuscular, thin film","copyable":false}],"toxicity":[{"kind":"LD50","organisms":[["Mouse",[{"kind":"LD50","organism":"Mouse","route":"oral","dose":"10-30"}]],["Rat",[{"kind":"LD50","organism":"Rat","route":"oral","dose":"100-150"}]]]}],"dosing":{"provider":"DBI-IGS (archived by anodyne.wiki)","routes":[{"method":"Oral","tiers":{"Common":{"lower":2.0,"upper":4.0,"unit":"","entries":null,"percentage":null},"Heavy":{"lower":4.0,"upper":6.0,"unit":"","entries":null,"percentage":null},"Light":{"lower":2.0,"upper":2.0,"unit":"","entries":null,"percentage":null},"Strong":{"lower":4.0,"upper":4.0,"unit":"","entries":null,"percentage":null},"Threshold":{"lower":1.0,"upper":2.0,"unit":"","entries":null,"percentage":null}}}]},"salts":[{"title":"Ondansetron dihydrochloride","name":"dihydrochloride","slug":"ondansetron_dihydrochloride","drawn":true}],"esters":[],"chirality":"racemic","stereo_type":"enantiomer","optical_activity":"( + / - )","stereoisomers":[{"name":"(R)-Ondansetron","href":"/substance/%28r%29-ondansetron"},{"name":"Ondansetron, (3S)-","href":"/substance/ondansetron,_%283s%29-"}],"lipinski":{"passes":true,"violations":0},"reagents":[],"atc":[{"code":"A","description":"Alimentary tract and metabolism"},{"code":"A04","description":"Antiemetics and antinauseants"},{"code":"A04A","description":"Antiemetics and antinauseants"},{"code":"A04AA","description":"Serotonin (5ht3) antagonists"},{"code":"A04AA01","description":""},{"code":"A04AA01","description":"Ondansetron"}],"mesh":[{"name":"Antiemetics","id":"M0001391"},{"name":"Antipruritics","id":"M0001498"},{"name":"Serotonin 5-HT3 Receptor Antagonists","id":"M0544719"}],"actives":[],"prodrugs":[],"codrug":false,"interactions":[{"target":"CYP3A4","mechanisms":["induction","metabolism","inhibition"],"partners":145,"contraindicated":0},{"target":"CYP2D6","mechanisms":["metabolism","inhibition","induction"],"partners":52,"contraindicated":0},{"target":"CYP1A2","mechanisms":["inhibition","metabolism","induction"],"partners":12,"contraindicated":0}],"mechanism":"Ondansetron is a selective antagonist of the serotonin receptor subtype, 5-HT3.  Cytotoxic chemotherapy and radiotherapy are associated with the release of serotonin (5-HT) from enterochromaffin cells of the small intestine, presumably initiating a vomiting reflex through stimulation of 5-HT3 receptors located on vagal afferents. Ondansetron may block the initiation of this reflex. Activation of vagal afferents may also cause a central release of serotonin from the chemoreceptor trigger zone of the area postrema, located on the floor of the fourth ventricle. Thus, the antiemetic effect of ondansetron is probably due to the selective antagonism of 5-HT3 receptors on neurons located in either the peripheral or central nervous systems, or both.  Although the mechanisms of action of ondansetron in treating postoperative nausea and vomiting and cytotoxic induced nausea and vomiting may share similar pathways, the role of ondansetron in opiate-induced emesis has not yet been formally established.","side_effects":{"drug_id":4595,"drug_name":"ondansetron","url":"https://sideeffects.embl.de/drugs/4595/pt","atc_codes":["A04AA01"],"side_effects":[{"name":"Wound","cui":"C0043250"},{"name":"Somnolence","cui":"C2830004"},{"name":"Headache","cui":"C0018681"},{"name":"Musculoskeletal pain","cui":"C0026858"},{"name":"Asthenia","cui":"C0004093"},{"name":"Fatigue","cui":"C0015672"},{"name":"Malaise","cui":"C0231218"},{"name":"Discomfort","cui":"C0234215"},{"name":"Feeling abnormal","cui":"C1443060"},{"name":"Ill-defined disorder","cui":"C2047937"},{"name":"Hypoxia","cui":"C0242184"},{"name":"Body temperature increased","cui":"C0015967"},{"name":"Genital disorder female","cui":"C0017411"},{"name":"Constipation","cui":"C0009806"},{"name":"Anxiety","cui":"C0003467"},{"name":"Agitation","cui":"C0085631"},{"name":"Bradycardia","cui":"C0428977"},{"name":"Dizziness","cui":"C0012833"},{"name":"Syncope","cui":"C0039070"},{"name":"Chills","cui":"C0085593"},{"name":"Urinary retention","cui":"C0080274"},{"name":"Dry mouth","cui":"C0043352"},{"name":"Anorectal discomfort","cui":"C2242737"},{"name":"Feeling hot","cui":"C2939147"},{"name":"Warmth","cui":"C0392197"},{"name":"Hypotension","cui":"C0020649"},{"name":"Pruritus","cui":"C0033774"},{"name":"Diarrhoea","cui":"C0011991"},{"name":"Injection site reaction","cui":"C0151735"},{"name":"Chest pain","cui":"C0008031"},{"name":"Dysuria","cui":"C0013428"},{"name":"Paraesthesia","cui":"C0030554"},{"name":"Feeling cold","cui":"C0234192"},{"name":"Procedural pain","cui":"C1619712"},{"name":"Dyskinesia","cui":"C0013384"},{"name":"Movement disorder","cui":"C0026650"},{"name":"Orofacial dyskinesia","cui":"C0152115"},{"name":"Convulsion","cui":"C0036572"},{"name":"Liver function test abnormal","cui":"C0151766"},{"name":"Anaphylactic shock","cui":"C0002792"},{"name":"Anaphylactoid reaction","cui":"C0340865"},{"name":"Angina pectoris","cui":"C0002962"},{"name":"Angioedema","cui":"C0002994"},{"name":"Arrhythmia","cui":"C0003811"},{"name":"Atrial fibrillation","cui":"C0004238"},{"name":"Bronchospasm","cui":"C0006266"},{"name":"Neoplasm malignant","cui":"C0006826"},{"name":"Cardiovascular disorder","cui":"C0007222"},{"name":"Dyspnoea","cui":"C0013404"},{"name":"Toxic epidermal necrolysis","cui":"C0014518"},{"name":"Eye disorder","cui":"C0015397"},{"name":"Flushing","cui":"C0016382"},{"name":"Hiccups","cui":"C0019521"},{"name":"Hypersensitivity","cui":"C0020517"},{"name":"Type I hypersensitivity","cui":"C0020523"},{"name":"Laryngeal oedema","cui":"C0023052"},{"name":"Laryngospasm","cui":"C0023066"},{"name":"Mediastinal disorder","cui":"C0025061"},{"name":"Myocardial infarction","cui":"C0027051"},{"name":"Acute coronary syndrome","cui":"C0948089"},{"name":"Nervous system disorder","cui":"C0027765"},{"name":"Pain","cui":"C0030193"},{"name":"Palpitations","cui":"C0030252"},{"name":"Shock","cui":"C0036974"},{"name":"Erythema multiforme","cui":"C0014742"},{"name":"Stevens-Johnson syndrome","cui":"C0038325"},{"name":"Stridor","cui":"C0038450"},{"name":"Loss of consciousness","cui":"C0041657"},{"name":"Supraventricular tachycardia","cui":"C0039240"},{"name":"Torsade de pointes","cui":"C0040479"},{"name":"Tremor","cui":"C0040822"},{"name":"Urticaria","cui":"C0042109"},{"name":"Angiopathy","cui":"C0042373"},{"name":"Vomiting","cui":"C0042963"},{"name":"Hepatic failure","cui":"C0085605"},{"name":"Oculogyric crisis","cui":"C0085637"},{"name":"Ventricular extrasystoles","cui":"C0151636"},{"name":"Myocardial ischaemia","cui":"C0151744"},{"name":"Opisthotonus","cui":"C0151818"},{"name":"Accommodation disorder","cui":"C0152198"},{"name":"Blindness transient","cui":"C0155003"},{"name":"Atrioventricular block second degree","cui":"C0264906"},{"name":"Hepatobiliary disease","cui":"C0267792"},{"name":"Erythema","cui":"C0041834"},{"name":"Vision blurred","cui":"C0344232"},{"name":"Blindness","cui":"C0456909"},{"name":"Electrocardiogram ST segment depression","cui":"C0520887"},{"name":"Procedural nausea","cui":"C1868752"},{"name":"Injection site pain","cui":"C0151828"},{"name":"Dystonia","cui":"C0393593"},{"name":"Visual impairment","cui":"C3665347"},{"name":"Cardio-respiratory arrest","cui":"C0600228"},{"name":"Local reaction","cui":"C0853813"},{"name":"Electrocardiogram QT prolonged","cui":"C0151878"},{"name":"Lymphocyte transformation test positive","cui":"C1141863"},{"name":"Toxic skin eruption","cui":"C0521465"},{"name":"Abdominal pain","cui":"C0000737"},{"name":"Gastrointestinal pain","cui":"C0687713"},{"name":"Asthma","cui":"C0004096"},{"name":"Cough","cui":"C0010200"},{"name":"Ear disorder","cui":"C0013447"},{"name":"Dermatitis","cui":"C0011603"},{"name":"Rash","cui":"C0015230"},{"name":"Flatulence","cui":"C0016204"},{"name":"Gastrointestinal disorder","cui":"C0017178"},{"name":"Cardiac disorder","cui":"C0018799"},{"name":"Haemorrhage","cui":"C0019080"},{"name":"Haemoglobin","cui":"C0518015"},{"name":"Hypokalaemia","cui":"C0020621"},{"name":"Immune system disorder","cui":"C0021053"},{"name":"Liver disorder","cui":"C0023895"},{"name":"Hepatocellular injury","cui":"C0151763"},{"name":"Foetor hepaticus","cui":"C0239571"},{"name":"Sleep disorder","cui":"C0851578"},{"name":"Swelling","cui":"C0038999"},{"name":"Tachycardia","cui":"C0039231"},{"name":"Urinary tract infection","cui":"C0042029"},{"name":"Aspartate aminotransferase increased","cui":"C0151904"},{"name":"Skin disorder","cui":"C0037274"},{"name":"Akathisia","cui":"C0392156"},{"name":"Grand mal convulsion","cui":"C0014549"}],"indications":[{"name":"Nausea","cui":"C0027497"},{"name":"Nausea postoperative","cui":"C0520904"},{"name":"Neoplasm malignant","cui":"C0006826"},{"name":"Vomiting","cui":"C0042963"}]},"effects":null,"usernotes":[],"erowid":[{"id":116139,"title":"Feeling the Cool Liquid Spread","author":"saucepapi","substances":"Ketamine, Lorazepam & Ondansetron","published":"2022 Feb 28","rating":"Recommended"}],"reddit":[{"id":"qxyd6k","title":"Trip Report: Eutylone, 5-MAPB, MDMA","author":"Wes_Wylde","score":4,"posted_on":"2021-11-20","url":"https://reddit.com/r/tripreports/comments/qxyd6k/trip_report_eutylone_5mapb_mdma/"},{"id":"1gjq8pl","title":"MDMA and ondansetron(zofran) combination ","author":"sporeson","score":1,"posted_on":"2024-11-04","url":"https://reddit.com/r/tripreports/comments/1gjq8pl/mdma_and_ondansetronzofran_combination/"}],"legal":[{"jurisdiction":"Australia","status":"Schedule 4","act":null,"refs":[3]},{"jurisdiction":"Canada","status":"Prescription only","act":null,"refs":[4]},{"jurisdiction":"United Kingdom","status":"Prescription only","act":null,"refs":[5]},{"jurisdiction":"United States","status":"Prescription only","act":null,"refs":[]},{"jurisdiction":"European Union","status":"Prescription only","act":null,"refs":[6]}],"members":[],"part_of":[],"links":[{"source":"Wikipedia","url":"https://en.wikipedia.org/wiki/Ondansetron"},{"source":"PubChem","url":"https://pubchem.ncbi.nlm.nih.gov/compound/4595"},{"source":"Wikidata","url":"https://www.wikidata.org/wiki/Q410011"},{"source":"DrugBank","url":"https://go.drugbank.com/drugs/DB00904"},{"source":"ChEMBL","url":"https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL46"},{"source":"ChEBI","url":"https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI%3A7773"},{"source":"Common Chemistry","url":"https://commonchemistry.cas.org/detail?cas_rn=99614-02-5"},{"source":"HMDB","url":"https://hmdb.ca/metabolites/HMDB0005035"},{"source":"KEGG","url":"https://www.kegg.jp/entry/C07325"},{"source":"EPA DSSTox","url":"https://comptox.epa.gov/dashboard/chemical/details/DTXSID8023393"},{"source":"Effect Index","url":"https://www.effectindex.com/search?q=Ondansetron"},{"source":"UNII","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/4AF302ESOS"},{"source":"SIDER","url":"https://sideeffects.embl.de/drugs/4595/pt"},{"source":"Erowid","url":"https://www.erowid.org/experiences/exp_search.cgi"}],"references":["National Center for Biotechnology Information. PubChem Compound Summary for CID 4595, Ondansetron. Accessed November 20, 2026. <a href=https://pubchem.ncbi.nlm.nih.gov/compound/4595>https://pubchem.ncbi.nlm.nih.gov/compound/4595</a>","U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Ondansetron. UNII: 4AF302ESOS. Global Substance Registration System. Accessed November 20, 2026. <a href=https://gsrs.ncats.nih.gov/ginas/app/beta/substances/4AF302ESOS>https://gsrs.ncats.nih.gov/ginas/app/beta/substances/4AF302ESOS</a>","Zofran Product and Consumer Medicine Information Licence. TGA eBS. <a href='http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&amp;id=CP-2013-PI-01055-1'>http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&amp;id=CP-2013-PI-01055-1</a>","Zofran Product information. Health Canada. 25 April 2012. <a href='https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&amp;code=43116'>https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&amp;code=43116</a>","Zofran Tablets 4 mg - Summary of Product Characteristics (SmPC). (emc). 19 January 2022. <a href='https://www.medicines.org.uk/emc/product/195/smpc'>https://www.medicines.org.uk/emc/product/195/smpc</a>","List of nationally authorised medicinal products: Active substance: ondansetron :Procedure no.: PSUSA/00002217/202102. Ema.europa.eu. <a href='https://www.ema.europa.eu/documents/psusa/ondansetron-list-nationally-authorised-medicinal-products-psusa/00002217/202102_en.pdf'>https://www.ema.europa.eu/documents/psusa/ondansetron-list-nationally-authorised-medicinal-products-psusa/00002217/202102_en.pdf</a>"],"sources":[{"source":"dosing","status":"ok","fetched_at":"2026-11-20 16:00:42","note":null},{"source":"drugspro","status":"missing","fetched_at":"2026-11-20 16:00:38","note":"no DrugsPRO reagent data"},{"source":"erowid","status":"ok","fetched_at":"2026-11-20 16:00:40","note":null},{"source":"gsrs","status":"ok","fetched_at":"2026-11-20 16:00:39","note":null},{"source":"hmdb","status":"missing","fetched_at":"2026-11-20 16:00:38","note":"hmdb.ca refused automated access to HMDB0005035"},{"source":"kegg","status":"ok","fetched_at":"2026-11-20 16:00:40","note":null},{"source":"pubchem","status":"ok","fetched_at":"2026-11-20 16:00:36","note":null},{"source":"reddit","status":"ok","fetched_at":"2026-11-20 16:00:38","note":null},{"source":"sider","status":"ok","fetched_at":"2026-11-20 16:00:38","note":null},{"source":"structure","status":"ok","fetched_at":"2026-11-20 16:00:38","note":null},{"source":"wikipedia","status":"ok","fetched_at":"2026-11-20 16:00:38","note":null}],"description":"Ondansetron is a  substance."}